This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …

HBV reactivation (HBVr) can be prevented by nucleos (t) ide analogues (NAs). We
conducted a systematic review and meta-analysis on the risk of HBVr associated with new …

Objectives To develop EULAR recommendations for screening and prophylaxis of chronic
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …

Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …

Portal hypertension (PH) drives most of the clinical complications in chronic liver diseases.
However, its progression in nonalcoholic steatohepatitis (NASH) and its association with the …

Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …

Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben,
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …

Objective To conduct a systematic literature review (SLR) on the screening and prophylaxis
of opportunistic and chronic infections in autoimmune inflammatory rheumatic diseases …

Anti-tumor necrosis factor (TNF)-α agents represent an effective treatment for chronic
inflammatory diseases. However, some concerns about their potentially undesirable effects …

Accompanying the increased use of biological and non-biological antirheumatic drugs, a
greater number of cases of hepatitis B virus (HBV) reactivation have been reported in …